A treatment strategy to help select patients who may not need secondary intervention to remove symptomatic ureteral stones after previous stenting.
Double J
Pre-stenting
Spontaneous stone passage
Ureteral stone
Urolithiasis
Journal
World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
18
10
2019
accepted:
06
01
2020
pubmed:
22
1
2020
medline:
22
6
2021
entrez:
22
1
2020
Statut:
ppublish
Résumé
This study aimed at evaluating whether removal of the ureteral stent the day before scheduled secondary intervention facilitates spontaneous ureteral stone passage and thus can spare the pre-stented patient this surgery. Retrospective analysis of a single-centre consecutive series of 216 patients after previous stenting due to a symptomatic ureteral stone from 01/2013 to 01/2018. Indwelling stents were removed under local anaesthesia. Patients were told to filter their urine overnight. Multivariate analysis was performed to assess predictive factors for spontaneous stone passage. 34% (74/216) of patients had spontaneous stone passage while the stent was indwelling. Of the remaining 142 patients, 41% (58/142) had spontaneous stone passage within 24 h after stent removal. Only 84/216 (39%) patients needed secondary intervention. Multivariate logistic regression analysis of all 216 patients showed a significant association between spontaneous stone passage and smaller stone size (p < 0.001), distal stone location (p = 0.046) and stent dwell time (p = 0.02). Predictive factors for spontaneous stone passage after stent removal were smaller size (p < 0.001), distal location (p = 0.001), and stone movement while the stent was indwelling (p = 0.016). A treatment strategy was established that helps select patients suitable for conservative management. The majority (61%) of ureteral stones passed spontaneously after pre-stenting; 34% while the stent was indwelling, 27% within 24 h after stent removal. Besides distal stone location, stone size (< 6 mm) and stone movement (≥ 5 cm) while the stent is indwelling indicate patients who are likely to pass their ureteral stone spontaneously after stent removal. The treatment strategy (decision tree) presented here helps identify those patients. https://doi.org/10.1186/ISRCTN12112914 .
Identifiants
pubmed: 31960109
doi: 10.1007/s00345-020-03087-1
pii: 10.1007/s00345-020-03087-1
doi:
Banques de données
ISRCTN
['ISRCTN12112914']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2955-2961Références
Scales CD Jr, Smith AC, Hanley JM, Saigal CS (2012) Urologic diseases in America project. Prevalence of kidney stones in the United States. Eur Urol 62:160–165
doi: 10.1016/j.eururo.2012.03.052
Parks JH, Coe FL (1994) An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int 45:1722–1730
doi: 10.1038/ki.1994.224
Skolarikos A, Laguna MP, Alivizatos G, Kural AR, de la Rosette JJ (2010) The role for active monitoring in urinary stones: a systematic review. J Endourol 24:923–930
doi: 10.1089/end.2009.0670
Bader MJ, Eisner B, Porpiglia F, Preminger GM, Tiselius H-G (2012) Contemporary management of ureteral stones. Eur Urol 61:764–772
doi: 10.1016/j.eururo.2012.01.009
European Association of Urology (EAU) Guidelines on Urolithiasis: https://uroweb.org/guideline/urolithiasis/
Assimos D, Crisci A, Culkin D et al (2016) Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int 117:648–654
doi: 10.1111/bju.13250
Jessen JP, Breda A, Brehmer M et al (2016) International collaboration in endourology: multicenter evaluation of prestenting for ureterorenoscopy. J Endourol 30:268–273
doi: 10.1089/end.2015.0109
Jones BJ, Ryan PC, Lyons O, Grainger R, McDermott TE, Butler MR (1990) Use of the double pigtail stent in stone retrieval following unsuccessful ureteroscopy. Br J Urol 66:254–256
doi: 10.1111/j.1464-410X.1990.tb14922.x
Lennon GM, Thornhill JA, Grainger R, McDermott TE, Butler MR (1997) Double pigtail ureteric stent versus percutaneous nephrostomy: effects on stone transit and ureteric motility. Eur Urol 31:24–29
doi: 10.1159/000474413
Baumgarten L, Desai A, Shipman S et al (2017) Spontaneous passage of ureteral stones in patients with indwelling ureteral stents. Can J Urol 24:9024–9029
Millman S, Strauss AL, Parks JH, Coe FL (1982) Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int 22:366–370
doi: 10.1038/ki.1982.183
Nakada SY, Hoff DG, Attai S, Heisey D, Blankenbaker D, Pozniak M (2000) Determination of stone composition by noncontrast spiral computed tomography in the clinical setting. Urology 55:816–819
doi: 10.1016/S0090-4295(00)00518-5
Becker G (2007) Uric acid stones. Nephrology 12:S21–25
doi: 10.1111/j.1440-1797.2007.00774.x
Venkatesh R, Landman J, Minor SD et al (2005) Impact of a double-pigtail stent on ureteral peristalsis in the porcine model: initial studies using a novel implantable magnetic sensor. J Endourol 19:170–176
doi: 10.1089/end.2005.19.170
Ryan PC, Lennon GM, McLean PA, Fitzpatrick JM (1994) The effects of acute and chronic JJ stent placement on upper urinary tract motility and calculus transit. Br J Urol 74:434–439
doi: 10.1111/j.1464-410X.1994.tb00418.x
Taha DE, Elshal AM, Zahran MH, Harraz AM, El-Nahas AR, Shokeir AA (2015) After urgent drainage of an obstructed kidney by internal ureteric stenting: is ureteroscopic stone extraction always needed? Arab J Urol 13:258–263
doi: 10.1016/j.aju.2015.09.002
Türk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S (2017) European Association of Urology. Medical expulsive therapy for ureterolithiasis: the EAU recommendations in 2016. Eur Urol 71:504–507
doi: 10.1016/j.eururo.2016.07.024
Loftus C, Nyame Y, Hinck B et al (2016) Medical expulsive therapy is underused for the management of renal colic in the emergency setting. J Urol 195:987–991
doi: 10.1016/j.juro.2015.11.026
Davenport K, Timoney AG, Keeley FX (2006) A comparative in vitro study to determine the beneficial effect of calcium-channel and alpha(1)-adrenoceptor antagonism on human ureteric activity. BJU Int 98:651–655
doi: 10.1111/j.1464-410X.2006.06346.x
Moradi M, Abdi H, Ebrahimi S, Rezaee H, Kaseb K (2017) Effects of Tamsulosin and Tolterodine on double J stent-related symptoms: a double-blind, randomized, placebo-controlled trial. SAGE Open Med 5:2050312117696436
doi: 10.1177/2050312117696436
Pais VM Jr, Smith RE, Stedina EA, Rissman CM (2016) Does omission of ureteral stents increase risk of unplanned return visit? A systematic review and meta-analysis. J Urol 196:1458–1466
doi: 10.1016/j.juro.2016.05.109
Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169:1065–1069
doi: 10.1097/01.ju.0000048980.33855.90
Lee C, Kuskowski M, Premoli J, Skemp N, Monga M (2005) Randomized evaluation of ureteral stents using validated symptom questionnaire. J Endourol 19:990–993
doi: 10.1089/end.2005.19.990